Skip to main content
. 2022 Dec 9;12(12):2041. doi: 10.3390/jpm12122041

Table 2.

Univariate and multivariate analysis for OS in patients with ICC.

Variables Overall Survival
Univariate Analysis
Overall Survival
Multivariate Analysis
HR 95% CI p-Value HR 95% CI p-Value
Age (≥56 vs. <56) 1.725 0.916–3.248 0.091
Gender (male vs. female) 0.977 0.718–1.330 0.883
Cirrhosis (yes vs. no) 1.146 0.614–2.138 0.669
Tumor number (multiple vs. single) 1.757 0.953–3.239 0.071
Tumor size (>5 cm vs. ≤5 cm) 1.800 0.963–3.364 0.065
Vascular invasion 2.992 1.615–5.543 <0.001 * 2.347 1.216–4.530 0.011 *
Pathology microvascular invasion 1.311 0.681–2.523 0.418
Pathology nerve tract invasion 2.846 1.490–5.437 0.002 * 3.018 1.536–5.927 0.001 *
Pathology differentiation degree (Moderate to poor, poor vs. well, well to moderate, moderate) 1.483 0.719–3.056 0.286
AFP (≥25 vs. <25) 1.236 0.521–2.935 0.631
CA19-9 (≥35 vs. <35) 2.653 1.410–4.989 0.002 * 2.071 1.030–4.167 0.041 *
CEA (≥5 vs. <5) 3.384 1.818–6.300 <0.001 * 1.965 0.880–3.746 0.107
PIVKA-II (≥40 vs. <40) 0.463 0.182–1.180 0.107
History of cholelithiasis 1.660 0.909–3.032 0.099
Hepatitis B 0.920 0.502–1.687 0.788
HALP (≥43.63 vs. <43.63) 1.258 0.662–2.391 0.483
NLR (≥3.73 vs. <3.73) 0.475 0.238–0.946 0.034 * 1.463 0.691–3.098 0.320
PLR (≥76.51 vs. <76.51) 0.217 0.030–1.580 0.132

Notes: * p < 0.05.